Arlington, MA, United States of America

Paul D Lynch


Average Co-Inventor Count = 6.0

ph-index = 4

Forward Citations = 54(Granted Patents)


Company Filing History:


Years Active: 2004-2016

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Paul D. Lynch: Innovator in Pharmaceutical Purification

Introduction

Paul D. Lynch is a notable inventor based in Arlington, MA, who has made significant contributions to the field of pharmaceuticals. With a total of six patents to his name, Lynch has focused on the purification and production of lipopeptides, particularly daptomycin, which is crucial for antibiotic therapies.

Latest Patents

Lynch's latest patents revolve around high purity lipopeptides. His inventions disclose highly purified daptomycin and pharmaceutical compositions that include this compound. The methods he has developed for purifying daptomycin involve sequential steps of anion exchange chromatography, hydrophobic interaction chromatography, and further anion exchange chromatography. Additionally, he has introduced a modified buffer enhanced anion exchange chromatography method for purification. His work also includes improved fermentation methods for producing daptomycin and high-pressure liquid chromatography techniques for analyzing daptomycin purity. Furthermore, Lynch has explored the creation of lipopeptide micelles and their therapeutic applications, including methods for purifying lipopeptide antibiotics like daptomycin.

Career Highlights

Lynch is currently associated with Cubist Pharmaceuticals, Incorporated, where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing the methods used for antibiotic purification and production, which are vital for effective medical treatments.

Collaborations

Some of Lynch's notable coworkers include Thomas J. Kelleher and Jan-Ji Lai, who have collaborated with him on various projects within the pharmaceutical industry.

Conclusion

Paul D. Lynch's contributions to the field of pharmaceutical purification highlight his innovative spirit and dedication to improving antibiotic therapies. His patents and ongoing work at Cubist Pharmaceuticals underscore the importance of advancements in this critical area of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…